THE AFRICA TIMES | KENYA — The government has made foundational investments in primary healthcare, health products, and digital systems to strengthen service delivery and expand access to quality care.
Local Vaccine Production Initiative
Medical Services Principal Secretary (PS) Dr. Ouma Oluga noted that Kenya’s experience during the COVID-19 pandemic exposed the risks associated with overreliance on imported vaccines. Delays in accessing vaccines during the global crisis underscored the urgent need to build local manufacturing capacity.
Speaking on Wednesday during a tour of the Kenya BioVax Institute facility in Embakasi by the French Minister for International Development, Ms. Éléonore Caroit, Dr. Oluga highlighted Kenya’s commitment to enhancing health security. He emphasized the importance of reducing reliance on imports and improving access
